GlassScriptPhysician profile
Marc F Matarazzo
NPI 1083678452
$20,964.71
in general payments reported to CMS, 2019-2025
20 companies · $5,117 in 2025
The $5,117 reported for 2025 was more than what 81% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,290 · 2020: $6,056 · 2021: $2,472 · 2022: $760 · 2023: $361 · 2024: $4,909 · 2025: $5,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,811 · Travel and Lodging: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,811.13 |
| Travel and Lodging | $1,576.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $10,720.07 | 2019-2025 | Mako, Insignia, Augment Injectable |
| Pylant Medical | $3,343.22 | 2020-2021 | |
| Arthrex, INC. | $2,852.26 | 2020-2024 | |
| Southern Edge Orthopaedics, INC. | $2,191.23 | 2019-2025 | |
| Moximed, INC | $774.22 | 2025 | Misha Knee System, Small, Left |
| Smith+Nephew, INC. | $363.61 | 2019-2024 | Journey II, Real Intelligence |
| Depuy Synthes Sales INC. | $122.57 | 2023-2024 | Orthovisc |
| Medical Device Business Services, INC. | $94.18 | 2019 | |
| Vericel Corporation | $83.47 | 2021-2025 | Maci |
| Embody, INC. | $81.32 | 2022 | |
| Ermi LLC | $78.00 | 2019-2025 | |
| Medacta USA, INC. | $66.29 | 2022 | |
| Kerecis Limited | $35.76 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $33.33 | 2025 | Kyphon Express II Kyphopak Tray |
| Pacira Pharmaceuticals Incorporated | $29.45 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.89 | 2024 | |
| Bioventus LLC | $20.93 | 2019 | |
| Carbofix Orthopedics INC | $19.53 | 2022 | |
| Electronic Waveform Lab, INC. | $15.96 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $13.42 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Matarazzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.